Journal of Antimicrobial Chemotherapy (2000) 45, 887-890
© 2000 The British Society for Antimicrobial Chemotherapy
Brief reports |
Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French hospitals
French National Reference Centre for Staphylococci, Unité des Staphylocoques, Institut Pasteur, 28, rue du Docteur Roux, 75724 Paris Cedex 15, France
Twenty-five different Staphylococcus aureus strains that are widespread in France were screened by various methods for heterogeneous and low-level resistance to vancomycin. Population analysis on brain–heart infusion agar containing 4 mg/L of the drug detected resistant cells at frequencies of 10–7 to 10–6 in five multiply resistant strains. There was no antagonism between vancomycin and ß-lactam antibiotics. One of the five strains, isolated in 1993, was considered a putative progenitor of a French nosocomial S. aureus strain isolated in 1998 and for which the vancomycin MIC was 8 mg/L.
* Corresponding author. Tel: +33-1-45688363; Fax: +33-1-40613163.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Cui, A. Iwamoto, J.-Q. Lian, H.-m. Neoh, T. Maruyama, Y. Horikawa, and K. Hiramatsu Novel Mechanism of Antibiotic Resistance Originating in Vancomycin-Intermediate Staphylococcus aureus Antimicrob. Agents Chemother., February 1, 2006; 50(2): 428 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. F. J. Brown, D. I. Edwards, P. M. Hawkey, D. Morrison, G. L. Ridgway, K. J. Towner, M. W. D. Wren, and on behalf of the Joint Working Party of the Britis Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA) J. Antimicrob. Chemother., December 1, 2005; 56(6): 1000 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Sancak, S. Ercis, D. Menemenlioglu, S. Colakoglu, and G. Hascelik Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital J. Antimicrob. Chemother., September 1, 2005; 56(3): 519 - 523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Asseray, C. Jacqueline, V. Le Mabecque, E. Batard, D. Bugnon, G. Potel, and J. Caillon Activity of Glycopeptides against Staphylococcus aureus Infection in a Rabbit Endocarditis Model: MICs Do Not Predict In Vivo Efficacy Antimicrob. Agents Chemother., February 1, 2005; 49(2): 857 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Huang, W. J. Brown, and M. J. Rybak In Vitro Activities of a Novel Cephalosporin, CB-181963 (CAB-175), against Methicillin-Susceptible or -Resistant Staphylococcus aureus and Glycopeptide-Intermediate Susceptible Staphylococci Antimicrob. Agents Chemother., July 1, 2004; 48(7): 2719 - 2723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Trad, J. Allignet, L. Frangeul, M. Davi, M. Vergassola, E. Couve, A. Morvan, A. Kechrid, C. Buchrieser, P. Glaser, et al. DNA Macroarray for Identification and Typing of Staphylococcus aureus Isolates J. Clin. Microbiol., May 1, 2004; 42(5): 2054 - 2064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Bert, J. Clarissou, F. Durand, D. Delefosse, C. Chauvet, P. Lefebvre, N. Lambert, and C. Branger Prevalence, Molecular Epidemiology, and Clinical Significance of Heterogeneous Glycopeptide-Intermediate Staphylococcus aureus in Liver Transplant Recipients J. Clin. Microbiol., November 1, 2003; 41(11): 5147 - 5152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. El Solh, M. Davi, A. Morvan, H. A. Damon, N. Marty, and the other members of the GISA group, RAISIN subgro Characteristics of French methicillin-resistant Staphylococcus aureus isolates with decreased susceptibility or resistance to glycopeptides J. Antimicrob. Chemother., October 1, 2003; 52(4): 691 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Gustafson, F. G. O'Brien, G. W. Coombs, M. J. Malkowski, W. B. Grubb, R. F. Pfeltz, and B. J. Wilkinson Alterations in phage-typing patterns in vancomycin-intermediate Staphylococcus aureus J. Med. Microbiol., August 1, 2003; 52(8): 711 - 714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-W. Decousser, P. Pina, F. Picot, C. Delalande, B. Pangon, P. Courvalin, P. Allouch, and the ColBVH study group Frequency of isolation and antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections: a French prospective national survey J. Antimicrob. Chemother., May 1, 2003; 51(5): 1213 - 1222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Haroche, A. Morvan, M. Davi, J. Allignet, F. Bimet, and N. El Solh Clonal Diversity among Streptogramin A-Resistant Staphylococcus aureus Isolates Collected in French Hospitals J. Clin. Microbiol., February 1, 2003; 41(2): 586 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Cui, X. Ma, K. Sato, K. Okuma, F. C. Tenover, E. M. Mamizuka, C. G. Gemmell, M.-N. Kim, M.-C. Ploy, N. El Solh, et al. Cell Wall Thickening Is a Common Feature of Vancomycin Resistance in Staphylococcus aureus J. Clin. Microbiol., January 1, 2003; 41(1): 5 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Heym, M. Le Moal, L. Armand-Lefevre, and M.-H. Nicolas-Chanoine Multilocus sequence typing (MLST) shows that the 'Iberian' clone of methicillin-resistant Staphylococcusaureus has spread to France and acquired reduced susceptibility to teicoplanin J. Antimicrob. Chemother., September 1, 2002; 50(3): 323 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Denis, C. Nonhoff, B. Byl, C. Knoop, S. Bobin-Dubreux, and M. J. Struelens Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features J. Antimicrob. Chemother., September 1, 2002; 50(3): 383 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Tallent, T. Bischoff, M. Climo, B. Ostrowsky, R. P. Wenzel, and M. B. Edmond Vancomycin Susceptibility of Oxacillin-Resistant Staphylococcus aureus Isolates Causing Nosocomial Bloodstream Infections J. Clin. Microbiol., June 1, 2002; 40(6): 2249 - 2250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-N. Kim, S. H. Hwang, Y.-J. Pyo, H.-M. Mun, and C. H. Pai Clonal Spread of Staphylococcus aureus Heterogeneously Resistant to Vancomycin in a University Hospital in Korea J. Clin. Microbiol., April 1, 2002; 40(4): 1376 - 1380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Benquan, T. Yingchun, Z. Kouxing, Z. Tiantuo, Z. Jiaxing, and T. Shuqing Staphylococcus Heterogeneously Resistant to Vancomycin in China and Antimicrobial Activities of Imipenem and Vancomycin in Combination against It J. Clin. Microbiol., March 1, 2002; 40(3): 1109 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Trakulsomboon, S. Danchaivijitr, Y. Rongrungruang, C. Dhiraputra, W. Susaemgrat, T. Ito, and K. Hiramatsu First Report of Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Vancomycin in Thailand J. Clin. Microbiol., February 1, 2001; 39(2): 591 - 595. [Abstract] [Full Text]
|
|
|
|
|
|
F. Guerin, A. Buu-Hoï, J.-L. Mainardi, G. Kac, N. Colardelle, S. Vaupré, L. Gutmann, and I. Podglajen Outbreak of Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Glycopeptides in a Parisian Hospital J. Clin. Microbiol., August 1, 2000; 38(8): 2985 - 2988. [Abstract] [Full Text]
|
|